Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

NCT07490041 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Rheumatic Diseases
Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)
Systemic Lupus Erythematosus (SLE)
Connective Tissue Disease-associated Interstitial Lung Disease

Interventions

BIOLOGICAL: KN5601

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]